Propensity score analysis demonstrates no long term survival benefit from contemporary endovascular aneurysm repair compared to open in Aotearoa New Zealand

Author:

Gormley Sinead12ORCID,Bernau Oliver2,Xu William2,Khashram Manar12ORCID

Affiliation:

1. Department of Vascular & Endovascular Surgery Waikato Hospital Hamilton New Zealand

2. Faculty of Medical & Health Sciences University of Auckland Auckland New Zealand

Abstract

AbstractBackgroundCurrent guidelines for AAA management are based on landmark trials comparing EVAR and open aneurysm repair (OAR) conducted more than 20 years ago. Important advancements have been made in peri‐operative care but the impact of EVAR and OAR on long‐term patient survival has not been well reported using contemporary data. The objective of this study was to compare the short and long‐term outcomes of OAR and EVAR in the recent era.MethodsThis retrospective observational study included all patients undergoing intact AAA repair in NZ from 1st of January 2011 until 31st of December 2019. Data was collected from national administrative and clinical vascular databases and matched using unique identifiers. Time‐to‐event survival analyses was conducted using cox proportional hazard models to adjust for confounders and propensity score matching were used.ResultsTwo thousand two hundred and ninety‐seven patients had an intact AAA repair with a median (IQR) age of 75 (69–80) years; 494 (21.2%) patients were females and 1206 (53%) underwent EVAR. The 30‐day mortality for OAR and EVAR was 4.8% and 1.2%. The median (IQR) follow up was 5.2 (2.3–9.2) years. After propensity matching for co‐variates, the study cohort consisted of 835 patients in each matched group. Patients undergoing EVAR had a higher overall mortality (HR 1.48 (95% CI: 1.26–1.74) after adjusting for confounders compared to OAR.ConclusionAnalysis of survival following EVAR and OAR in the current era demonstrates that patients that underwent EVAR had a lower 30‐day mortality. However, in the long‐term after adjusting for confounders OAR had a better overall survival.

Publisher

Wiley

Subject

General Medicine,Surgery

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3